RVP (Retractable Technologies) Current Accrued Expense: $2.39 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVP Retractable Technologies Inc RVP
31 GF Score
Price $0.73
GF Value $0.71
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Retractable Technologies Current Accrued Expense?

Retractable Technologies RVP +1.14% 31 Current Accrued Expense is $2.39 Mil as of Jun. 2026. GuruFocus rates RVP with a GF Score™ of 31/100 and a GF Value™ of $0.71 (Fairly Valued). The stock has 3 warning signs investors should review.

Retractable Technologies's Current Accrued Expense for the quarter that ended in Jun. 2026 was $2.39 Mil.

Retractable Technologies's quarterly Current Accrued Expense increased from Dec. 2025 ($1.35 Mil) to Mar. 2026 ($1.72 Mil) and increased from Mar. 2026 ($1.72 Mil) to Jun. 2026 ($2.39 Mil).

Retractable Technologies's annual Current Accrued Expense declined from Dec. 2023 ($1.81 Mil) to Dec. 2024 ($1.29 Mil) but then increased from Dec. 2024 ($1.29 Mil) to Dec. 2025 ($1.35 Mil).

Retractable Technologies Current Accrued Expense Related Terms

Retractable Technologies Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Retractable Technologies's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Retractable Technologies Current Accrued Expense Chart

Retractable Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.84 2.53 1.81 1.29 1.35

Retractable Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.51 1.35 1.72 2.39
RVP
31GF Score
Retractable Technologies Inc RVP
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Retractable Technologies Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $2.39 Mil mean?
Retractable Technologies (RVP) has a Current Accrued Expense of $2.39 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Retractable Technologies and its competitors.
Is Retractable Technologies' Current Accrued Expense too high?
Retractable Technologies' current Current Accrued Expense is $2.39 Mil. Overall, Retractable Technologies has a GF Score™ of 31/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' Current Accrued Expense compare to ZJYL and RGNT?
Retractable Technologies' Current Accrued Expense of $2.39 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Retractable Technologies and its competitors. Retractable Technologies's current Current Accrued Expense is $2.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Fairly Valued. The stock's GF Value™ is $0.71, compared to a current price of $0.73 — trading 2.8% above its estimated fair value. The current Current Accrued Expense is $2.39 Mil. Retractable Technologies' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Retractable Technologies (RVP), the current Current Accrued Expense is $2.39 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Retractable Technologies (RVP) Overvalued in 2026?

Based on GuruFocus' analysis, Retractable Technologies stock appears to be overvalued. The current stock price of $0.73 is trading 2.8% above its estimated GF Value™ of $0.71. GuruFocus considers Retractable Technologies to be Fairly Valued.

Key valuation signals for RVP:

  • Current Accrued Expense: $2.39 Mil
  • GF Value™: $0.71 vs. price of $0.73 (2.8% above fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Retractable Technologies Business Description

Address 511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
31GF Score

Get the complete analysis for RVP

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.73
Price
$0.71
GF Value